Clinical Trials Directory

Trials / Completed

CompletedNCT01708304

Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)

From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
510 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRDADExercise training for caregiver and care recipient. Behavioral modification training for caregiver.

Timeline

Start date
2012-11-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2012-10-16
Last updated
2017-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01708304. Inclusion in this directory is not an endorsement.